This requirement stood in contrast to the longstanding International Workshop on Waldenstrom’s Macroglobulinemia definition of LPL/WM [57], which allowed for recognition of LPL involving < 10% of bone marrow cellularity. The gene discussed is LPL; the disease is macroglobulinemia.